Vicasinabin

DB21587InvestigationalSmall molecule

Vicasinabin is a small molecule drug. Vicasinabin is under investigation in clinical trial NCT04265261 (A Study to Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type... Vicasinabin has a monoisotopic molecular weight of 358.2 Da.

Formula / weight: C₁₅H₂₂N₁₀O · 358.41 g/mol (avg)
Code names: RG-7774 · RO-6868847

Resolves to

Compound

UNIIQJ8UO6C05MCAS1433361-02-4ChEMBLCHEMBL5314566ChEBI759264PubChem86296048

Structure

InChIKeyMAYZWDRUFKUGGP-VIFPVBQESA-NSMILESCN1N=NN=C1CN1N=NC2=C(N=C(N=C12)C(C)(C)C)N1CC[C@H](O)C1

Targets

P34972CNR2

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Vicasinabin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account